drugset / Trial / NCT06077682
Cycloplegic Refraction in Pediatric Patients With Esotropia
Phase 4
Unknown
100 enrolled
Islamic Hospital, Jordan
Jordan University of Science and Technology · collabYarmouk University · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The primary outcome of this study is to compare cyclopentolate 1% and tropicamide 1% for cycloplegic refractions in pediatric populations with esotropia. This will be a prospective double-blinded randomized clinical trial (RCT), multi-center, with randomized sequencing of cycloplegic agent; each patient received one agent at one visit, and the other agent in the next visit (2 different visits ≥ 1 week apart) within 3 months.
Timeline
- Start
- 2023-09-01
- Primary completion
- 2024-09-01
- Completion
- 2024-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | cyclopentolate | Unknown | 1 % | Other |
| Comparator | tropicamide | Small molecule | 1 % | Other |